One More Chinese COVID-19 Vaccine Enters Late-Stage Human Trials


Source: freshnewsasia.com freshnewsasia.com

Key Topics in this News Article:

News Snapshot:

One More Chinese COVID-19 Vaccine Enters Late-Stage Human Trials Hits: 63 - 20/11/20 20:45 Hits: 63 HEFEI, Nov. 20 (Xinhua) -- Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. has commenced phase-3 clinical trials for its COVID-19 vaccine, planning to recruit 29,000 volunteers across the world. This is China's first phase-3 efficacy study for a recombinant subunit COVID-19 vaccine candidate, the company said in a statement on Thursday. Jointly developed by the company and the Institute of Microbiology under the Chinese Academy of Sciences, the vaccine was issued with a clinical research permit from the National Medical Products Administration...